CapVest Acquires Majority Stake in Stada, Abandoning IPO Plans
CapVest Partners, a London-based private equity firm, has agreed to acquire a majority stake in German pharmaceutical company Stada Arzneimittel, effectively halting the drugmaker’s previously explored initial public offering (IPO).
CapVest | 02/09/2025 | By Darshana | 167
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy